Citryll completes € 18.5 M fundraise to develop CIT-013, an antibody targeting Neutrophil Extracellular Traps

https://www.curiecapital.nl/wp-content/uploads/2020/07/Press-release-second-closing-final-2020-Citryll-with-IK.pdf

Sirius Medical announces CE mark for Pintuition: a non-radioactive localization system to improve breast cancer surgery

https://www.curiecapital.nl/wp-content/uploads/2020/06/001263_SiriusMedicalPR-CErelease.pdf